期刊文献+

降糖药达格列净中2种杂质的合成 被引量:6

Synthesis of Two Impurities in Dapagliflozin
下载PDF
导出
摘要 为定量控制降糖药达格列净中的杂质,对达格列净中的2个杂质5-溴-2-氯-2′-乙氧基二苯甲酮(1)和5-溴-2-氯-2′-乙氧基二苯甲烷(2)进行了定向合成,以5-溴-2-氯苯甲酸和苯酚经缩合、Fries重排,然后乙基化得到杂质1,杂质1再经还原得到杂质2。其结构经核磁共振氢谱和质谱确证结构。 To perform the quality control of dapagliflozin, two impurities of dapagliflozin including 5-bromo-2-chlorophenyl-2′-ethoxyldiphenylmethanone(1) and 5-bromo-2-chloro-2′-ethoxyl diphenylmethane(2) were synthesized. Impurity 1 was prepared via condensation, Fries rearrangement and ethylation using 5-bromo-2-chlorobenzoic acid and phenol as the starting materials. Impurity 2 was obtained from reduction of impurity 1.The structures of Impurity 1 and Impurity 2 were characterized using1 H NMR and MS.
出处 《精细化工中间体》 CAS 2016年第3期24-27,共4页 Fine Chemical Intermediates
基金 国家"重大新药创制"科技重大专项(2009ZX09301-012)
关键词 达格列净 杂质 合成 dapagliflozin impurity synthesis
  • 相关文献

参考文献7

  • 1秘芳,董金华.达格列净[J].中国药物化学杂志,2014,24(4):332-333. 被引量:6
  • 2Pal M.Improved process for the preparation of SGLT2 inhibitor dapagliflozin via glycosylation of 5-bromo-2-chloro-4'-ethoxydiphenylmethane with gluconolactone:IN,2010CH03942A[P].2012-10-19.
  • 3秦延涛.一种达格列净异构体杂质的合成方法:中国,105061373A[P].2015-11-18.
  • 4Kwon E M,Kim C G,Jun J G,et al.Preparation of benzoyloxy benzophenone derivatives and their inhibitory effects of icam-1expression[J].Bull Korean Chem Soc,2012,33(6):1 939-1 944.
  • 5Olah G A,Arvanaghi M,Krishnamurthy V V.Heterogeneous catalysis by solid superacids polymeric perfluorinated resin sulfonic acid(Nafion-H)catalyzed fries rearrangement of aryl esters[J].J Org Chem,1983,48(19):3 359-3 360.
  • 6Massah A R,Mosharafian M,Momeni A R,et al.Solvent-free Williamson synthesis:an efficient,simple,and convenient method for chemoselective etherification of phenols and bisphenols[J].Synthetic Commun,2007,37(11):1 807-1 815.
  • 7禹艳坤,冀亚飞.达格列净的合成[J].中国医药工业杂志,2011,42(2):84-87. 被引量:15

二级参考文献11

  • 1Bailey CJ,Gross JL,Pieters A,et al.Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin:a randomized,double-blind,placebocontrolled trial[J].Lancet,2010,375(9733):2223-2233.
  • 2Meng W,Ellsworth BA,Nirschl AA,et al.Discovery of dapagliflozin:a potent,selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes[J].JMedChem,2008,51 (5):1145-1149.
  • 3Eckhardt M,Eickelmann P,Himmelsbach F,et al.Glucopyranosyl-substituted benzonitrile derivatives,pharmaceutical compositions containing such compounds,their use and process for their manufacture:WO,2007093610[P].2007-08-23.(CA 2007,147:277850).
  • 4Song YL,Chen YW,Cheng HW,et al.Benzylbenzenederivatives and methods of use:WO,2009026537[P].2009-02-26.(CA 2009,150:237833).
  • 5Liou J,Wu YL,Li SB,et al.Processes for the preparation of SGLT2 inhibitors:WO,2010022313[P].2010-02-25.(CA 2010,152:287663).
  • 6CHEN Z H,WANG R W,QING F L.Synthesis and biological evaluation of SGLT2 inhibitors:gem-difluoromethylenated dapagliflozin analogs[J].Tetrahedron Lett,2012,53(17):2171-2176.
  • 7MENG W,ELLSWORTH B A,NIRSCHL A A,et al.Discovery of dapagliflozin:a potent,selective renal sodium-dependent glucose cotransporter 2(SGLT2)inhibitor for the treatment of type 2 diabetes[J].J Med Chem,2008,51(5):1145-1149.
  • 8KASICHAYANULA S,CHANG M,HASEGAWA M,et al.Pharmacokinetics and pharmacodynamics of dapagliflozin,a novel selective inhibitor of sodium-glucose co-transporter type 2,in Japanese subjects without and with type 2 diabetes mellitus[J].Diab Obes Metab,2011,13(4):357-365.
  • 9KOMOROSKI B,VACHHARAJANI N,BOULTON D,et al.Dapagliflozin,a novel SGLT2 inhibitor,induces dose-dependent glucosuria in healthy subjects[J].Clin Pharmacol Ther,2009,85(5):520-526.
  • 10巫凤娟,杨臻峥,孙大柠.降糖药 Dapagliflozin[J].药学进展,2009,33(7):334-336. 被引量:6

共引文献18

同被引文献39

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部